Congress Spotlight: Merz Aesthetics® Unveils Ultherapy PRIME® at 2025 IMCAS
Merz Aesthetics is launching Ultherapy PRIME® across Europe, the Middle East, and Africa, marking an exciting evolution of the non-invasive Ultherapy® skin lifting technology. This advanced version of Ultherapy® promises enhanced results and a more efficient treatment process for those seeking non-surgical solutions to skin lifting and tightening.
In addition to the launch, Merz Aesthetics is showcasing its commitment to the field of regenerative aesthetics by presenting six abstracts at the 2025 International Master Course on Aging Science (IMCAS) World Congress. These presentations highlight the company’s diverse product portfolio and its significant contributions to advancing aesthetic medicine. Through these efforts, Merz Aesthetics continues to push the boundaries of innovation in regenerative treatments, reaffirming its position as a leader in the aesthetics industry.
Merz Aesthetics, a leader in medical aesthetics, is unveiling its next-generation Ultherapy PRIME® device in Europe, the Middle East, and Africa (EMEA). This latest innovation is an advancement of the non-invasive Ultherapy® skin lifting technology that has helped revolutionize the aesthetics field. Ultherapy PRIME® offers a customizable, long-lasting treatment option that combines proven technology with enhanced capabilities for a superior, non-invasive lifting experience.
According to Gonzalo Mibelli, EMEA President of Merz Aesthetics, the launch of Ultherapy PRIME® demonstrates the company’s ongoing commitment to innovation. “As one of the leaders in non-invasive lifting, we’re excited to bring Ultherapy PRIME to our customers as the next-generation, premier platform in aesthetics,” said Mibelli.
The launch of Ultherapy PRIME® is complemented by Merz Aesthetics’ participation in the 2025 International Master Course on Aging Science (IMCAS) World Congress, where the company is showcasing its leadership in regenerative aesthetics. The IMCAS Congress provides a unique platform for Merz Aesthetics to present its innovations in the field of aesthetics, and this year’s focus is on regenerative treatments.
Dr. Kerstin Olsson, Head of Medical Affairs EMEA at Merz Aesthetics, shared her perspective on the growing demand for regenerative aesthetic solutions. “Patients are looking for more sustainable ways to address aging, and regenerative aesthetic treatments provide both preventive and restorative methods to improve skin health and enhance long-term confidence,” said Olsson. By collaborating with experts in aesthetics and aging science, Merz Aesthetics aims to showcase its advancements in these fields during the Congress.
Merz Aesthetics has organized an exciting program for the IMCAS event, with a series of expert-led presentations and sessions. The company’s Symposium, titled “Regenerative Aesthetics: Elevating Skin, Lifting Confidence,” will feature a lineup of renowned medical professionals, including Dr. Joyce Lim, Dr. Julia Sevi, Dr. Tatjana Pavicic, Dr. Omar Haroon, and Dr. Daria Voropai. This session, scheduled for Saturday, February 1, from 10:30 AM to 12:30 PM, will explore the latest breakthroughs in regenerative aesthetics.
Additionally, Dr. Sabrina Fabi will kick off the Ultherapy PRIME® Golden Lounge on Thursday, January 30, at 12:30 PM. Throughout the event, Merz Aesthetics is organizing multiple expert roundtable discussions, including a session on “Non-invasive Regenerative Biostimulation” led by Dr. Tatjana Pavicic, Dr. Kerstin Ortlechner, and Dr. Sonja Sattler, as well as a talk on “The Importance of Visualization” with Dr. Julia Sevi, Dr. Daria Voropai, and Dr. Kerstin Ortlechner.
In addition to these thought-provoking presentations, Merz Aesthetics is hosting various product analysis sessions, including a detailed exploration of “HA Skinboosters” by Dr. Mimi Borelli, Global Medical Affairs at Merz Aesthetics, on Thursday, January 30. The company’s CEO, Bob Rhatigan, will also be participating in the IMCAS Congress Economic Tribune Roundtable on Friday, January 31, from 4:00 PM to 6:00 PM.
Merz Aesthetics will also be engaging with attendees at its booth with several key talks, such as “Connecting with Confidence: Global Insights for a More Patient-Centered Approach” by Dr. Shannon Humphrey, scheduled for Thursday, January 30, at 2:30 PM. Further presentations will cover topics such as optimizing results, standing out in the competitive aesthetic marketplace, and synergistic strategies for décolleté treatment in mature patients.
Beyond the live sessions, Merz Aesthetics will also feature e-poster presentations throughout the Congress, highlighting significant studies and research in the field of regenerative aesthetics. These include posters on the effects of CaHA microspheres in improving skin elasticity, exploring the mechanisms of action behind elastin stimulation, and reviewing global perspectives on aesthetic treatments for skin quality improvement.
Merz Aesthetics’ contributions to the regenerative aesthetics field extend far beyond Ultherapy PRIME®Congress. The company has built a diverse portfolio of clinically proven products designed to meet the needs of patients while maintaining high standards of safety and efficacy. As a family-owned company with more than 115 years of experience, Merz Aesthetics continues to foster strong, long-term relationships with its customers. Its global headquarters is located in Raleigh, N.C., USA, with a commercial presence in over 90 countries. Merz Aesthetics is part of the Merz Group, a company founded in 1908 and headquartered in Frankfurt, Germany.
The launch of Ultherapy PRIME® and Merz Aesthetics’ ongoing presence at major industry events like IMCAS Congress reflects the company’s dedication to driving innovation in regenerative aesthetics. As aging-related concerns become increasingly important for patients, Merz Aesthetics remains committed to providing advanced, non-invasive solutions that offer both preventive and restorative benefits. Through continuous research, collaboration, and product development, Merz Aesthetics is poised to lead the way in the future of aesthetic medicine.
